Lifevantage (LFVN)
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, no...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Lifevantage Analyst Rating
View moreForecast & Rating
Sep 1, 2026Price forecast
$7.5018.11%
Forecast & RatingBuy
2analysts
- Strong buy50.00%
- Buy0.00%
- Hold50.00%
- Sell0.00%
- Strong sell0.00%
News
- Baystreet · 23 hours ago
LifeVantage Heralds Part in Conference, Shares Show Gains
- PUBT · 1 day ago, 12:01 PM
LifeVantage CEO, CFO to present at WTR Virtual Insights Conference
- PUBT · 1 day ago, 08:06 PM
LifeVantage director Darwin Lewis acquires 976 shares worth $6,070.72
- Simplywall · Sep 16 at 12:32 PM
Have LifeVantage Insiders Been Selling Stock?
- Simplywall · Aug 31 at 12:25 PM
LifeVantage Corporation (NASDAQ:LFVN) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
- Tip Ranks · Aug 31 at 06:00 AM
LifeVantage’s AI Push Heightens Regulatory, Legal and Cyber Risks Amid Competitive Pressures
